76 Results

People

  1. Yu
    Yu
  2. Riely
    Riely
  3. Kris
    Kris
  4. Ladanyi
    Ladanyi
  5. Arcila
    Arcila
  6. Drilon
    Drilon
  7. Rudin
    Rudin
  8. Jones
    Jones
  9. Offin
    Offin
  10. Schoenfeld
    Schoenfeld

Groups

  1. Department of Medicine (58)
  2. Solid Tumor Oncology Division (56)
  3. Thoracic Oncology (53)
  4. GSK Faculty (15)
  5. Department of Pathology and Laboratory Medicine (14)
  6. Human Oncology and Pathogenesis Program (13)
  7. Sloan Kettering Institute Postdocs (13)
  8. Graduate Medical Education (11)
  9. Weinberg Fellows (11)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (10)
  1. "osimertinib"
Formats
  1. Journal Article (43)
  2. Editorial (10)
  3. Meeting Abstract (9)
  4. Review (8)
  5. Guidelines (3)
  6. Conference Paper (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (58)
  2. Solid Tumor Oncology Division (56)
  3. Thoracic Oncology (53)
  4. GSK Faculty (15)
  5. Department of Pathology and Laboratory Medicine (14)
  6. Human Oncology and Pathogenesis Program (13)

More Groups

People
  1. Helena Yu (37)
  2. Gregory Riely (15)
  3. Mark Kris (11)
  4. Marc Ladanyi (10)
  5. Bob Li (7)
  6. Maria Arcila (7)

More People

Years
  1. 2025 (6)
  2. 2024 (17)
  3. 2023 (8)
  4. 2022 (10)
  5. 2021 (10)
  6. 2020 (4)

More Years

Publications
  1. Journal of Thoracic Oncology (14)
  2. Clinical Cancer Research (9)
  3. Annals of Oncology (8)
  4. Cancer Discovery (7)
  5. Journal of Clinical Oncology (5)
  6. Journal of Thoracic and Cardiovascular Surgery (4)

More Publications

Publishers
  1. Elsevier Inc. (17)
  2. American Association for Cancer Research (16)
  3. Oxford University Press (9)
  4. American Society of Clinical Oncology (7)
  5. Elsevier Science, Inc. (4)
  6. Mosby Elsevier (4)

More Publishers

Results (76)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer
    Journal Article

    Bang, A. S.; Said, J. T.; Hirner, J.; Rana, J.; Pugliese, S.; Wang, J. Y.; Zaba, L.; Zhao, L.; Doan, L.; Smith, J.; more...
    Supportive Care in Cancer (2024)

    Fulltext@MSK | Save
  • Surgery for oligometastatic non–small cell lung cancer
    Editorial

    Antonoff, M. B.; Deboever, N.; Werner, R.; Altan, M.; Gomez, D.; Opitz, I.
    Journal of Thoracic and Cardiovascular Surgery (2024)

    Fulltext@MSK | Save
  • POSing the question: MARIPOSA-2, do the ends justify the means?
    Editorial

    Chen, M. F.; Piotrowska, Z.; Yu, H. A.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Intracranial outcomes of de novo brain metastases treated with osimertinib alone in patients with newly diagnosed EGFR-mutant NSCLC
    Journal Article

    Imber, B. S.; Sehgal, R.; Saganty, R.; Reiner, A. S.; Ilica, A. T.; Miao, E.; Li, B. T.; Riely, G. J.; Yu, H. A.; Panageas, K. S.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Advances in CAR T cell therapy for non-small cell lung cancer
    Review

    Ma, H. Y.; Das, J.; Prendergast, C.; De Jong, D.; Braumuller, B.; Paily, J.; Huang, S.; Liou, C.; Giarratana, A.; Hosseini, M.; more...
    Current Issues in Molecular Biology (2023)

    Fulltext@MSK | Save
  • The promise and limitations of neoadjuvant immune-checkpoint blockade in resectable non–small cell lung cancer
    Editorial

    Cooper, A. J.; Yu, H. A.
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Osimertinib and selpercatinib efficacy, safety, and resistance in a multicenter, prospectively treated cohort of EGFR-mutant and RET fusion-positive lung cancers
    Journal Article

    Rotow, J.; Patel, J. D.; Hanley, M. P.; Yu, H.; Awad, M.; Goldman, J. W.; Nechushtan, H.; Scheffler, M.; Kuo, C. H. S.; Rajappa, S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Efficacy of osimertinib in patients with lung cancer positive for uncommon EGFR exon 19 deletion mutations
    Journal Article

    Grant, M. J.; Aredo, J. V.; Starrett, J. H.; Stockhammer, P.; van Alderwerelt van Rosenburgh, I. K.; Wurtz, A.; Piper-Valillo, A. J.; Piotrowska, Z.; Falcon, C.; Yu, H. A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer
    Conference Paper

    Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
    Mosby Elsevier (2023)

    Fulltext@MSK | Save
  • Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas
    Journal Article

    Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save